Quality Investment Offering Quarterly Income


Comprehensive Market Reports

Comprehensive Market Reports

PathFree Expansion LLC is a promising investment opportunity poised for long-term growth, based on our portfolio of innovative medical devices developed by PathFree Technologies Corporation. These patented products, including the PathFree Intelligent Code Cart, PathFree Expandable Endotracheal Tube, PathFree Wrist-mounted Aerosol Vacuum Filter, and PathFree Septum Monitor, cater to various sectors within the healthcare industry.

The global markets for medical carts, endotracheal tubes, aerosol monitoring, and vital signs monitoring are all projected to witness significant growth in the coming years, driven by factors such as technological advancements, increasing prevalence of chronic diseases, rising demand for improved patient care, and a growing geriatric population.

Investing in PathFree Expansion LLC offers the potential to capitalize on the growth of these medical device markets, as the company’s innovative products revolutionize patient care and gain market share. This makes PathFree Expansion LLC an attractive investment opportunity for those seeking long-term growth in the healthcare sector.

See The Comprehensive Market Reports Below:

PathFree AiMediQ AiCart Market

The global medical carts market is projected to witness significant growth in the coming years, driven by the increasing adoption of technology in healthcare and the rising demand for enhanced patient care. The PathFree AiMediQ AiCart is an innovative product designed to streamline emergency medical response procedures, providing a more efficient and user-friendly experience for healthcare professionals.

Key factors contributing to the growth of the Intelligent Code Cart market include:

The rising demand for improved emergency medical care

The increasing need for organized and efficient medical equipment storage

The growing geriatric population requiring increased medical attention

Technological advancements in the medical carts market

The Available Market for AiMediQ AiCart is Immense

The Vast Potential of AiMediQ AiCart in the Healthcare Industry

The American Hospital Association’s statistics reveal a staggering number of 6,090 hospitals across the United States as of 2019. This data alone emphasizes the immense market potential for AiCart within the healthcare industry. Moreover, the Urgent Care Association recorded an astounding 9,616 urgent care facilities within the country in 2021. Additionally, the Health Resources & Services Administration reports over 10,000 community health clinics, also known as Federally Qualified Health Centers, in the U.S.

Expanding Opportunities in the United States

Considering that most healthcare facilities require multiple AiCarts to cater to their needs, the market for AiMediQ AiCart within the United States alone is enormous. However, it’s important to note that these figures don’t even account for a vast array of private practices, specialist clinics, or other healthcare establishments. The potential number of such establishments could easily reach the tens of thousands, if not more. This further amplifies the opportunities for AiMediQ AiCart to penetrate various segments of the healthcare industry.

Global Reach and Limitless Possibilities

The aforementioned statistics primarily focus on the United States, but the market potential for AiMediQ AiCart extends far beyond its borders. Medical facilities worldwide, including hospitals, urgent care centers, community health clinics, private practices, specialist clinics, and numerous other healthcare service providers, present an expansive market for AiMediQ AiCart. As the demand for advanced technology and efficient healthcare solutions continues to rise globally, AiMediQ AiCart has the potential to make a significant impact on a global scale.

Unexplored Markets and Future Growth

It’s essential to highlight that the statistics mentioned earlier don’t even encompass long-term care establishments, such as nursing homes, mental health care facilities, rehabilitation centers, and other healthcare service providers. These segments of the healthcare industry present untapped markets for AiMediQ AiCart, providing opportunities for expansion and further growth.

The available market for AiMediQ AiCart is truly immense, with countless healthcare facilities in the United States and a global network of medical establishments that could benefit from its innovative solutions. As the demand for advanced healthcare technology continues to rise, AiMediQ AiCart has the potential to become a leading player in the industry, revolutionizing the way healthcare providers deliver their services and enhancing patient care on a global scale. With its wide range of applications and limitless possibilities, AiMediQ AiCart is poised for remarkable success in the ever-evolving healthcare landscape.

PathFree AiMediQ AiCart Market Reports

Product Variations

AiMediQ MediQ(PathResponder): The Essential ACLS Companion for Pre-Hospital Care

Empowering Emergency Response with Compact Intelligence:

AiMediQ MediQ(PathResponder) isn’t just a medical device; it’s a lifeline for healthcare professionals in pre-hospital settings. This compact and portable system serves as the core platform for PathFree’s solutions, equipping medical teams with everything they need to manage critical ACLS situations effectively.

Why It Matters to Equity Investors:

Addressing a Growing Market: The demand for advanced pre-hospital care is rising, driven by aging populations and increasingly complex medical emergencies. AiMediQ MediQ offers a solution that fills a critical gap, making it a highly attractive investment opportunity.

Unmatched ACLS Support: AiMediQ MediQ boasts:

Real-time vital sign monitoring: Keep track of patients’ vital signs with continuous monitoring and data visualization.

Onboard diagnostic tools: Perform essential checks like ECG, pulse oximetry, and blood pressure measurements to inform treatment decisions.

Secure communication capabilities: Stay connected with hospitals and specialists for seamless transfer and consultation.

Rugged and portable design: Built for the harshest conditions, AiMediQ MediQ thrives in ambulances, helicopters, and challenging environments.

Data-Driven Insights: Like AiMediQ AiCart, MediQ collects valuable data on ACLS procedures, enabling continuous improvement and data-backed decision-making. This data further strengthens your case for investors.

Scalability and Accessibility: AiMediQ MediQ’s compact size and modular design make it adaptable to various pre-hospital settings, from large ambulance fleets to small first-responder vehicles. This broadens its market reach and potential return on investment.

The MediQ has the potential to:

Save lives: By improving ACLS efficiency and accuracy, AiMediQ MediQ can directly impact patient survival rates.

Optimize resource allocation: Accurate data insights can guide strategic decisions and improve resource allocation within healthcare systems.

Empower pre-hospital teams: Providing first responders with the tools they need to make informed decisions improves confidence and performance in critical situations.

PathFree Technologies’ AiMediQ MediQ (PathResponder) represents a significant advancement in pre-hospital emergency care, particularly in Advanced Cardiovascular Life Support (ACLS) situations. This device, designed to be compact and portable, is specifically tailored for use in pre-hospital settings like ambulances and emergency response vehicles. It offers a range of functionalities that address the growing demand for advanced pre-hospital care driven by an aging population and increasingly complex medical emergencies.

The AiMediQ MediQ (PathResponder) is equipped with capabilities crucial for effective ACLS support in pre-hospital environments. These include real-time monitoring of vital signs, onboard diagnostic tools for essential checks such as ECG, pulse oximetry, and blood pressure measurements, and secure communication features to ensure seamless coordination with hospitals and specialists. Its rugged and portable design makes it ideal for use in various challenging conditions.

In addition to its practical features, the AiMediQ MediQ (PathResponder) collects valuable data on ACLS procedures, similar to the AiMediQ AiCart. This data collection is pivotal for continuous improvement and informed decision-making, which is particularly attractive to equity investors. The device’s scalable and adaptable design allows it to fit different pre-hospital settings, enhancing its market reach and potential investment returns.

PathFree Technologies emphasizes the use of Artificial Intelligence (AI) in their products, including the AiMediQ MediQ (PathResponder), to enhance their effectiveness in emergency situations. The integration of AI in these devices is seen as a step forward in revolutionizing emergency care, potentially improving patient survival rates and optimizing healthcare resources. The company’s focus on AI-driven solutions, like the AiMediQ AiCart, has been geared towards reducing knowledge gaps, minimizing human errors, and enhancing the efficiency of medical response teams in cardiopulmonary arrest situations​​​​​​​​​​.

AiMediQ MobileER (PathEmergency): The Ultimate ACLS Fortress for Mass Casualty Events

When Every Second Counts, There’s AiMediQ MobileER:

Imagine a self-contained, rapidly deployable medical unit, equipped with cutting-edge ACLS technology and capable of transforming into a fully functional treatment environment within minutes. That’s AiMediQ MobileER (PathEmergency) – the future of emergency response for large-scale events and disasters.

Why It Matters to Equity Investors:

Addressing a Critical Gap: Mass casualty events, from natural disasters to terrorist attacks, strain existing healthcare systems. AiMediQ MobileER offers a solution by providing immediate, high-quality ACLS care to a large number of patients simultaneously.

Unmatched ACLS Capability: AiMediQ MobileER boasts:

Modular design: Expandable units adapt to the scale of any emergency, ensuring efficient patient flow and treatment.

Advanced ACLS technology: Integrate AiMediQ’s core functionalities with additional medical equipment for comprehensive critical care.

Precision drone support: Digital twin technology guides medical drones for rapid aerial transportation, medication delivery, and patient triage.

Secure communication infrastructure: Seamlessly connect with hospitals and emergency networks for coordinated response and resource allocation.

Data-Driven Insights and Improvement: Real-time data gathering and analysis inform decision-making, optimize workflows, and ensure continuous improvement in disaster response.

Proven Technology and Leadership: Built on PathFree’s proven AiMediQ platform and backed by experienced leadership.

Global Market Impact: From earthquake zones to conflict areas, AiMediQ MobileER has the potential to save lives and improve emergency response worldwide, leading to substantial market reach and return on investment.

AiMediQ MobileER can:

Minimize fatalities: Rapid deployment and advanced ACLS capabilities save lives during critical hours after disasters.

Optimize resource allocation: Data-driven insights guide deployment and resource allocation, maximizing impact with limited resources.

PathFree Technologies’ AiMediQ MobileER (PathEmergency) is a groundbreaking development in the field of emergency response, especially for handling mass casualty events. This innovative device is engineered with the advanced features of PathFree’s AiMediQ technology, tailored for civilian use in emergency scenarios. Its key characteristics make it highly relevant for equity investors who are interested in the healthcare and emergency response sectors.

The AiMediQ MobileER offers a modular design, which allows it to adapt to various scales of emergencies, ensuring efficient patient flow and treatment. It integrates core functionalities of the AiMediQ platform with additional medical equipment, providing comprehensive critical care. One of the most notable features of the AiMediQ MobileER is its precision drone support, which utilizes digital twin technology for rapid aerial transportation, medication delivery, and patient triage. This feature enhances its capability to provide immediate, high-quality ACLS care to a large number of patients simultaneously.

The device is also equipped with a secure communication infrastructure, allowing seamless connectivity with hospitals and emergency networks for coordinated responses and resource allocation. In terms of data management, the AiMediQ MobileER gathers and analyzes real-time data to inform decision-making, optimize workflows, and ensure continuous improvement in disaster response scenarios.

PathFree Technologies’ brand AiMediQ emphasizes the integration of Artificial Intelligence (AI) and machine learning in their products, including the AiMediQ MobileER. AI in healthcare, particularly in critical care, is transformative, enabling predictive analytics, pattern recognition, and data-driven research that significantly improve patient outcomes and healthcare efficiency. The AiMediQ MobileER, like other AiMediQ products, is designed for continuous improvement, with AI capabilities allowing it to learn and adapt over time, thereby enhancing its effectiveness in emergency situations.

The combination of these advanced technologies and the device’s portability make it a valuable asset in emergency medical response, particularly in remote or challenging terrains and in situations where conventional medical response methods might be insufficient or too slow. The potential lifesaving impact of the AiMediQ MobileER is significant, especially in large-scale emergencies or mass casualty events where rapid deployment and advanced medical capabilities can dramatically reduce mortality rates.

AiMediQ AiMini (PathEvent): The Backpack-Sized Powerhouse for Event ACLS Preparedness

Safeguarding Crowds with Cutting-Edge Technology:

Large gatherings come with risks, and when it comes to ACLS preparedness, every second counts.

AiMediQ AiMini (PathEvent) – the compact, on-the-go solution for ensuring swift and effective response during potential medical emergencies at crowded events.

Why It Matters to Equity Investors:

Addressing a Growing Concern: Event safety is paramount, and AiMediQ AiMini tackles the rising concern of managing potential ACLS situations at concerts, sporting events, and other large gatherings.

Unmatched ACLS Readiness: AiMediQ AiMini boasts:

Essential vital sign monitoring: Track patients’ vitals in real-time and identify potential issues before they escalate.

Secure communication capabilities: Stay connected with medical teams and emergency responders for seamless coordination.

Digital twin training simulations: Utilize AiMediQ AiMini’s technology to train medical professionals on ACLS protocols and improve response preparedness.

Compact and portable design: Easily carried by event staff, security personnel, or even first responders for immediate deployment.

Data-Driven Insights and Improvement: Gather valuable data on event medical responses to refine protocols and optimize future preparedness.

Scalability and Accessibility: AiMediQ AiMini’s affordability and ease of use make it accessible to event organizers of all sizes, democratizing ACLS preparedness and safety standards.

A Proven Technology Legacy: Built on PathFree’s established AiMediQ platform, AiMediQ AiMini leverages trusted technology and expertise, making it a reliable investment.

Invest in Protecting Crowds, One Event at a Time:

By backing AiMediQ AiMini, you’re not just investing in a device; you’re investing in peace of mind and security for millions of people attending events worldwide. AiMediQ AiMini can:

Minimize panic and chaos: Rapid response and communication during medical emergencies prevent escalation and maintain a safe environment.

Empower event staff and first responders: Equip them with the tools and confidence to handle potential ACLS situations effectively.

Promote preventative healthcare: Early identification of potential issues through vital sign monitoring allows for proactive intervention and avoids escalation.

PathFree Technologies’ AiMediQ AiMini (PathEvent) is an innovative product tailored for providing ACLS support in crowded event settings. It represents a compact, portable solution designed to enhance safety and medical preparedness at large gatherings, such as concerts and sports events.

The AiMediQ AiMini incorporates essential features for ACLS readiness. It includes capabilities for real-time vital sign monitoring, which is crucial in quickly identifying and responding to potential medical issues before they escalate. Additionally, its secure communication capabilities ensure seamless coordination with medical teams and emergency responders, enhancing the efficiency of medical interventions during events.

One of the notable aspects of AiMediQ AiMini is its use of digital twin technology for training simulations. This technology helps in training medical professionals on ACLS protocols, thereby improving response preparedness for potential emergencies. Its compact and portable design makes it easily accessible and deployable by event staff, security personnel, or first responders, ensuring immediate action during emergencies.

PathFree Technologies’ brand AiMediQ emphasizes the integration of Artificial Intelligence (AI) and machine learning in its products, including AiMediQ AiMini. This integration facilitates enhanced medical response capabilities, such as predictive analytics for risk factor detection and proactive care, and pattern recognition for more accurate diagnoses and treatment plans. The AI features in AiMediQ AiMini and other AiMediQ products are designed to complement human expertise in healthcare, providing continuous monitoring and data analysis to improve patient outcomes.

Reinventing Emergency Response: The AiMediQ MediQ Drone Revolution

Intelligent Response Unit

Artificial Intelligence

Machine Learning

Predictive Analytics

Enhanced Training & Simulation

Automatic Inventory Management

Connects With Internet Of Things

Natural Language Processing


AiMini / AiMediQ

In the realm of rapid emergency response, the intersection of Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), and predictive analytics is paving the way for transformative innovations. At the forefront of these changes is the prospect of transforming the AiMediQ AiCart into a mini drone-able device. This innovative blend of technologies could overhaul the way healthcare decisions are made and redefine emergency responses.

Rapid and Unhindered Response

One of the critical benefits of drone-enabled AiMediQ technology is the speed at which help can reach those in need. Unlike traditional emergency services vehicles, drones can bypass the constraints of traffic, leading to a rapid response that can be crucial during emergencies. This capability to reach a destination quickly can make a significant difference in life-threatening situations.

Extending Reach to Remote Areas

Drones equipped with AiMediQ technology hold the potential to provide remote accessibility. They can easily reach areas where traditional emergency services might struggle, significantly expanding the reach of critical care and ensuring no location is left isolated during crises.

Real-Time Monitoring and Data Analysis

By integrating with the IoT and utilizing real-time data, drones can provide real-time monitoring. They can relay vital patient information back to medical professionals while en route, enabling immediate analysis and pre-arrival preparation at the patient’s location. This feature ensures that healthcare professionals can start planning the treatment even before reaching the scene.

Efficient Delivery of Medical Supplies

Another key function of these drone-able AiMediQ MediQs is the efficient delivery of medical supplies. This function becomes particularly vital in situations where immediate human response isn’t feasible or when the patient is in a remote location.

Cost-Effectiveness and Sustainability

Drone deployment also provides a cost-effective alternative to traditional methods. By reducing reliance on ambulances and other emergency vehicles, healthcare systems can cut down on costs significantly. Furthermore, as most drones are electric, they can also align with environmental sustainability goals, contributing to a reduced carbon footprint.

Enhanced Predictive Analysis

Enhanced predictive analysis is another significant advantage of combining AI, ML, and predictive analytics with drones. The system can further refine its predictions and guidance, leading to more accurate and effective treatments.

Personalized Care and Increased Efficiency

The utilization of AI and IoT also allows for more personalized care. The collected data can direct drones to cater to individual patient needs, making healthcare more tailored to each patient. Additionally, drones can also increase the efficiency of healthcare staff by handling transportation and preliminary monitoring tasks.

Collaboration, Training, and Psychological Comfort

By integrating with other emergency systems, drones can enable better collaboration. Moreover, they can serve as mobile platforms for training simulations, allowing medical professionals to practice in real-life scenarios. The knowledge of a rapid response possibility also provides psychological comfort to patients and their families, fostering trust in the healthcare system.

Scalability and Compliance

With the advancement of technology, the capabilities of drones can be expanded, ensuring scalability. By adhering to healthcare regulations and standards, drone-able AiMediQ MediQs can ensure a seamless and legally compliant integration into existing healthcare systems.

Disaster Response

In events of natural disasters or mass casualty incidents, drones equipped with AiMediQ technology can provide immediate response and support. This function makes them a vital tool in disaster response and large-scale emergencies.

Making the AiMediQ miniature and drone-able would not only capitalize on the existing technologies such as AI, IoT, ML, and predictive analytics but also open up new avenues to revolutionize emergency medical response, providing a more immediate, personalized, and effective care system. This innovative approach to healthcare could revolutionize emergency responses and significantly improve patient care and survival rates.

PathFree Expandable Endotracheal Tube Market

The global endotracheal tube market is expected to experience significant growth, driven by the increasing prevalence of respiratory disorders and the need for advanced airway management solutions. The PathFree Expandable Endotracheal Tube offers a unique solution for improved airway management, providing better patient outcomes.

Factors contributing to the growth of the Expandable Endotracheal Tube market include:

The rising prevalence of chronic respiratory diseases

Growing demand for airway management devices in emergency situations

Technological advancements in airway management devices Increasing adoption of disposable endotracheal tubes to reduce infection risks

PathFree Expandable Tracheal Tube

PathFree Wrist-mounted Aerosol Vacuum Filter Market

The aerosol monitoring market is expected to grow rapidly as industries and healthcare facilities become more focused on minimizing airborne particles to ensure safety and quality control. The PathFree Wrist-mounted Aerosol Vacuum Filter offers a portable and convenient solution for monitoring and measuring aerosol concentrations.

Key drivers of the Wrist-mounted Aerosol Vacuum Filter market include:

The growing need for improved air quality monitoring in healthcare settings

Increasing concerns about the spread of airborne diseases

Strict regulations and guidelines regarding air quality control

Advancements in aerosol monitoring technologies

PathFree Medical Air Filtration Device & PathFree Wrist-mounted Aerosol Vacuum Filter

PathFree Septum Monitor Market

The global vital signs monitoring market is anticipated to grow substantially due to the increasing prevalence of chronic diseases and the growing geriatric population. The PathFree Septum Monitor offers a non-invasive and innovative solution for continuous monitoring of patients’ vital signs.

Factors contributing to the growth of the Septum Monitor market include:

The increasing prevalence of cardiovascular diseases

The growing need for remote patient monitoring

Technological advancements in vital signs monitoring devices

Rising demand for non-invasive and continuous monitoring solutions

PathFree Septum Monitor

Investing in PathFree Expansion LLC provides an opportunity to capitalize on the growth of these innovative medical devices and their respective market sectors, offering long-term growth potential as the products gain market share and revolutionize patient care.

Forward-looking Statements

This website contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties, and other known and unknown factors that could cause actual results, events, or developments to differ materially from the results, events, or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, interest in, uptake of, and the ability to commercialize the Pathfree AiCart, our ability to develop, launch, commercialize, and/or maintain steady production of the AiCart, dependence on obtaining and maintaining regulatory approvals, including the acquisition of product certifications, and to obtain all necessary FDA authorizations. These factors should be carefully considered, and investors are cautioned not to place undue reliance on forward-looking statements. Despite PathFree Technologies Corporation’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. PathFree Technologies Corporation does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws.

Home » Comprehensive Market Reports





This information is provided by PitchBook

US Market Insights Q1 2024

Q4 2023 Medtech Report


Please contact your PathFree Expansion LLC representative to receive a complete investors package, including digital subscription documents with instructions and options for funding your investment.
Contact Us with Questions or Inquiries at:

1 (888) 83-PATHFREE

Email us at: info@pathfree.com

Watch, Read, Listen


Translate »